Log on / register
Feedback | Support | My details
Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen.
Mahler M, Raijmakers R, Dähnrich C, Blüthner M, Fritzler MJ
Arthritis Res Ther 2005, 7:R704-13
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Editorial    
The changing landscape of the clinical value of the PM/Scl autoantibody system
Mahler M, Fritzler MJ
Arthritis Research & Therapy 2009, 11:106 (26 March 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Research article    
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
Hanke K, Brückner CS, Dähnrich C, Huscher D, Komorowski L, Meyer W, Janssen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester GR, Hiepe F, Schlumberger W, Riemekasten G
Arthritis Research & Therapy 2009, 11:R22 (16 February 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.


Research article    
Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus
Mahler M, Waka A, Hiepe F, Fritzler MJ
Arthritis Research & Therapy 2007, 9:R68 (18 July 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.